T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 12/31/2014
Volatility and Other Measures
as of 01/31/2015
Beta 0.88
0.39
Standard Deviation 12.93
Price/Earnings Ratio (Domestic) 22.5
Earnings Growth Rate (Domestic) 15.4
Turnover Rate 2.9
Median Market
Capitalization
$27,944.45 Million
10 Largest Holdings
Represents 33.25 % of Total Net Assets
View Holdings as of:
Actavis plc
Aetna
Alexion Pharmaceuticals
Allergan
Biogen Idec
Gilead Sciences
McKesson
Pharmacyclics
UnitedHealth Group
Valeant Pharmaceuticals International
As of 12/31/2014 the Health Sciences Fund had a total of 160 holdings.
Sector Diversification
as of 01/31/2015
% of Total Net Assets
Biotechnology 32.4%
Services 24.2%
Pharmaceuticals 23.8%
Products & Devices 10.2%
Life Sciences 3.2%
Miscellaneous 2.5%
See Glossary for additional details on all data elements.